Neoplasia/BPH

	Tumor and Organ Dose Estimates from (177)Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial. J Nucl Med Ells Z, Meyer C, Masri K, Ryhiner M, Sennung D, Kimura K, Mirando D, Tworowska I, Esfandiari R, Allen-Auerbach MS, Lassmann M, Herrmann K, Eiber M, Fendler WP, Delpassand E, Czernin J, Dahlbom M, Calais J. PMID: 42532646 [PubMed - as supplied by publisher]
	Environmental exposome study for prostate cancer in elderly men from Western China: preliminary findings from a case-control study in the WeEndPd cohort. BMJ Open Zhou X, He Y, Jin Y, Peng Z, Zeng B, Zhang Z, Wu Y, Wei C, Mo Z, Cheng J, Chen Y, Wang F, Lu G, Tao K, Yang Z, Wu Y, Zhang W, Zhuang C, Guo W, Li G, Liu Y, Huang Y, Gao R, Zhan Y, Zou X, Yang L, Wei Q, Wei X, Qiu S. PMID: 42532568 [PubMed - indexed for MEDLINE]
	[Testicular Germ Cell Tumors and Penile Cancer: Molecular-Based Diagnosis and Treatment]. Aktuelle Urol Paffenholz P, Heidenreich A, Weiten R. PMID: 42532107 [PubMed - as supplied by publisher]
	Can prostate cancer be diagnosed with near certainty on MRI? Eur J Radiol Cummings C, Allen C, Dickinson L, Pendse D, Emberton M, Giganti F, Moore C, Woernle A, Freeman A, Haider A, Kirkham A. PMID: 42531699 [PubMed - as supplied by publisher]
	Assessing Geographic Disparities in the Availability of Renal Cell Carcinoma Clinical Trials in the United States. JCO Oncol Pract Zhang G, Fann J, Castro DV, Shah KU, Li X, Abreu de Goes V, Jaime-Casas S, Mercier B, Li YJ, Agarwal R, Dickter S, Dukkipati A, Goud J, Lau L, Lau LM, Lee J, Shah K, Simon R, Swarat E, Zugman M, Moradi A, Hsu J, Dizman N, Nguyen C, Chehrazi-Raffle A, Barragan-Carrillo R, Pal SK. PMID: 42531525 [PubMed - as supplied by publisher]
	Prognostic significance of TOP2A expression in bladder cancer: Systematic review and meta-analysis. Can Urol Assoc J Hendri AZ, Robert R, Febriyanto T, Liliana B, Pratama ADM, Oey O. PMID: 42531453 [PubMed - as supplied by publisher]
	Association between time from diagnosis to radical cystectomy and oncologic outcomes in muscle-invasive urothelial carcinoma of the bladder. Can Urol Assoc J Kim P, Kaul S, Fleishman A, Perez-Londono A, Kim S, Bellmunt J, Aghdam N, Olumi AF, Chang P, Wagner A, Gershman B. PMID: 42531446 [PubMed - as supplied by publisher]
	Investigation of a prostate cancer radiation response signature in the breast cancer SweBCG91RT randomized trial. Clin Cancer Res Zhao SG, Holmberg E, Lundstedt D, Killander F, Niméus E, Sharifi M, Sjöström M, Karlsson P. PMID: 42531378 [PubMed - as supplied by publisher]
	Concurrent Jackstone Calculus and Prostate Cancer: Should They Be Treated Concurrently or Sequentially? Am J Mens Health Tian S, Li H, Jiang Y, Wang C, Liu S, Wu F, Ning H. PMID: 42531155 [PubMed - indexed for MEDLINE]
	Patient-Provider Communication and Treatment Decision-Making among Latino Men with Prostate Cancer: A Qualitative Study. J Racial Ethn Health Disparities Rodriguez VE, Mendoza-Aguayo B, Rodriguez J, Ramirez CM, Soto D, Unger JB, Abreu AL, Ariani R, Baezconde-Garbanati L, Ballas L, Stern MC. PMID: 42530811 [PubMed - as supplied by publisher]
	Global trends and knowledge structure in robotic-assisted simple prostatectomy research: a bibliometric and visualized analysis. J Robot Surg Daniswara RR, Prakasa AE, Rabiansyah MK, Xius SL, Widjaja JB, Ginting MBW, Achmadsyah A, Ananda NF. PMID: 42530703 [PubMed - indexed for MEDLINE]
	The impact of prostate size on outcomes of aquablation: a prospective study. World J Urol Perez D, Mamber A, Pasherstnik M, Koulikov D, Natsheh AE, Shenfeld OZ, Kafka IZ, Chertin B. PMID: 42530631 [PubMed - indexed for MEDLINE]
	Kinesins in Bladder Cancer: Integrating Molecular Mechanisms and Treatment Approaches. Cell Biol Int Sayed U, Basheer NM, H M, Nayak PP, Shankhyan A, Eshmetov R, Sadikova S, Ataullaev Z. PMID: 42529891 [PubMed - indexed for MEDLINE]
	Mapping therapy-responsive immune ecotypes in clear cell renal cell carcinoma through integrative omics. Front Immunol Zhang Z, He L, Chen B, Zhang H. PMID: 42529102 [PubMed - indexed for MEDLINE]
	PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencing. Oncol Rev Gierulska N, Jankowska N, Kwiatkowska A, Kuchno P, , Szklener K, Ko, Skórzewska M. PMID: 42529062 [PubMed]
	Awareness, risk perception, and attitudes toward prostate cancer detection and MRI among Armenian men. Front Public Health Shalunc NN, Gaboyan SS, Matinyan NG, Mnatsakanyan TS, Hovhannisyan MG, Ergas IJ. PMID: 42529047 [PubMed - indexed for MEDLINE]
	Case Report: Immune checkpoint inhibitor-induced IgG4-related disease mimicking renal metastatic progression: successful steroid-sparing management with rituximab. Front Immunol Bonatto ME, Dvo, Kollár M, Girsa D, Pr, Forejtová , Mann H, Vencovský J, Pavelka K, . PMID: 42528919 [PubMed - indexed for MEDLINE]
	Per- and Polyfluoroalkyl Substances Exposure in New Jersey Prostate Cancer Survivors: A Pilot Biomonitoring Study. medRxiv Joseph SA, Opara C, Shanahan MR, Varga J, Falcon J, Ibanga U, Venkatraman S, Perlstein M, Jang TL, Golombos D, Ghodoussipour S, Fan T, O'Leary S, Graber JM, Hart JE, Barrett ES, Bandera EV, Iyer HS. PMID: 42528551 [PubMed]
	Trends in the Adoption of MRI Associated Biopsy for Active Surveillance Within the First Year After Localized Prostate Cancer Diagnosis: A SEER-Medicare Cohort Study. Cancer Med Liu Y, Polychronopoulou E, Jackson J, Williams S, Kuo YF. PMID: 42528154 [PubMed - indexed for MEDLINE]
	Prognostic Factor Analysis and Nomogram Development in Castration-Resistant Prostate Cancer with Visceral Metastases for Future Radionuclide Therapy Selection. Cancer Biother Radiopharm Xu P, Lin X, Zhu Y, Chen J, Yang B. PMID: 42528049 [PubMed - as supplied by publisher]

Articles 1 - 20 / 190140

Page 1 of 9507



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy